Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
2h
Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research ...
9h
Sanofi inks $1B deal to sell autoimmune disorder therapy
Sanofi (SNY) sells global rights to Enjaymo treatment for cold agglutinin disease to Recordati (RCDTF) in a deal worth up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US adds 254,000 jobs
Accused of sexual assault
Registration deadlines
US launches airstrikes
Antarctica turning green
Jan. 6 charges dismissal bid
Nevada politician guilty
Wreck of WWII ship found
To stay at rescue center
To stop linking to NZ news?
Read seeks to delay lawsuit
3 pitching coaches fired
Processing times drop
To weigh Mexico’s $10B suit
Plastic-eating bacteria
Water fluoridation research
Union skips endorsement
Murder case to be reviewed
Tropical Storm Leslie forms
CDC flu vaccine report
Senators urge DOJ action
Free tax filing expansion
CA dairy workers infected
Debt plan blocked again
First mpox test approved
To add Hyundai EVs
Nuclear waste storage case
Related topics
Regeneron
United States
Food and Drug Administration
Sanofi
Chronic obstructive pulmonary disease
Feedback